ExecSalaries
Home · Compare

Kimberly B. MacKay vs Mayukh Sukhatme

💰 How does your salary compare?
See how you rank against the world's top executives — free, instant, SEC-backed data
Try it →
Mayukh Sukhatme earned $250.6M (19918%) more than Kimberly B. MacKay in their most recent fiscal years on record.
CompanyWest Pharmaceutical ServicesRoivant Sciences
TitlePresidentPresident and Chief Investment Officer
IndustryHealthcareHealthcare
Fiscal YearFY2025FY2024
Total Pay$1.3M$251.9M
Base Salary$487,000$550,000
Stock Awards$424,255$170.2M
Bonus$81.1M
Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.
← Back to database · Kimberly B. MacKay's full profile · Mayukh Sukhatme's full profile
ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy